Other
Screening Assay for Inhibitors of Severe Acute Respiratory Syndrome (SARS) Using SELDI-TOF Mass Spectrometry
Pharmacology and Toxicology Faculty Publications
Document Type
Patent
Publication Date
11-16-2006
Disciplines
Abstract
Mass spectrometric methods directed to screening libraries of compounds for agents that inhibit entry of Severe Acute Respiratory Syndrome (SARS) coronavirus (CoV) into cells are provided, along with methods for comparatively evaluating inhibitors of the SARS CoV.
Citation Information
Khalid M. Elased and Mariana Morris. "Screening Assay for Inhibitors of Severe Acute Respiratory Syndrome (SARS) Using SELDI-TOF Mass Spectrometry" (2006) Available at: http://works.bepress.com/khalid_elased/48/
United States Patent Application US20060257861 A1